Yutaka Ohsawa

2.3k total citations
45 papers, 1.2k citations indexed

About

Yutaka Ohsawa is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Yutaka Ohsawa has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 14 papers in Cell Biology and 11 papers in Physiology. Recurrent topics in Yutaka Ohsawa's work include Muscle Physiology and Disorders (16 papers), Oral microbiology and periodontitis research (6 papers) and Caveolin-1 and cellular processes (6 papers). Yutaka Ohsawa is often cited by papers focused on Muscle Physiology and Disorders (16 papers), Oral microbiology and periodontitis research (6 papers) and Caveolin-1 and cellular processes (6 papers). Yutaka Ohsawa collaborates with scholars based in Japan, United States and Australia. Yutaka Ohsawa's co-authors include Yoshihide Sunada, Kazuhisa Yamazaki, T. Murakami, Hiromasa Yoshie, Takako Eguchi Nakajima, G. J. Seymour, H. Ito, Koichi Tabeta, Hiroki Hagiwara and Sumihare Noji and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Neurology.

In The Last Decade

Yutaka Ohsawa

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yutaka Ohsawa Japan 21 665 281 260 235 216 45 1.2k
Toshiaki Ara Japan 17 638 1.0× 189 0.7× 99 0.4× 154 0.7× 500 2.3× 37 1.8k
Yoshifumi Takahata Japan 20 860 1.3× 38 0.1× 151 0.6× 116 0.5× 190 0.9× 45 1.5k
Akiko Mizokami Japan 21 676 1.0× 33 0.1× 244 0.9× 80 0.3× 238 1.1× 60 1.5k
Tadahiko Iijima Japan 17 523 0.8× 67 0.2× 111 0.4× 42 0.2× 148 0.7× 36 977
Vu Thuong Nguyen United States 24 833 1.3× 32 0.1× 112 0.4× 85 0.4× 161 0.7× 38 1.9k
Denisse Sepúlveda Chile 12 182 0.3× 77 0.3× 196 0.8× 212 0.9× 51 0.2× 19 620
Haijiao Zhao China 13 225 0.3× 151 0.5× 229 0.9× 102 0.4× 48 0.2× 28 782
Lizheng Qin China 15 325 0.5× 73 0.3× 303 1.2× 47 0.2× 46 0.2× 42 861
Bradley K. Wacker United States 15 332 0.5× 29 0.1× 48 0.2× 80 0.3× 135 0.6× 24 721

Countries citing papers authored by Yutaka Ohsawa

Since Specialization
Citations

This map shows the geographic impact of Yutaka Ohsawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Ohsawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Ohsawa more than expected).

Fields of papers citing papers by Yutaka Ohsawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Ohsawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Ohsawa. The network helps show where Yutaka Ohsawa may publish in the future.

Co-authorship network of co-authors of Yutaka Ohsawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Ohsawa. A scholar is included among the top collaborators of Yutaka Ohsawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Ohsawa. Yutaka Ohsawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imamura, Keiko, Ayako Nagahashi, Kayoko Tsukita, et al.. (2025). iPSC screening identifies CACNA2D2 as a potential therapeutic target for FTLD-Tau. European Journal of Cell Biology. 104(2). 151484–151484.
2.
Shirotani, Keiro, Kaori Watanabe, Yumiko Kutoku, et al.. (2023). Alterations of ATG4A and LC3B in neurons derived from Alzheimer's disease patients. Genes to Cells. 28(4). 319–325.
3.
Ohsawa, Yutaka, Hideaki Ohtsubo, T. Murakami, et al.. (2023). Circulating α-Klotho Counteracts Transforming Growth Factor-β–Induced Sarcopenia. American Journal Of Pathology. 193(5). 591–607. 16 indexed citations
4.
Ohsawa, Yutaka, Hideaki Ohtsubo, Yoshihiko Saito, et al.. (2022). Caveolin 3 suppresses phosphorylation-dependent activation of sarcolemmal nNOS. Biochemical and Biophysical Research Communications. 628. 84–90. 2 indexed citations
5.
Ohsawa, Yutaka, et al.. (2022). Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy. Internal Medicine. 62(9). 1345–1349. 2 indexed citations
6.
Ohsawa, Yutaka, Hiroki Hagiwara, Shin‐ichiro Nishimatsu, et al.. (2018). Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. Journal of Neurology Neurosurgery & Psychiatry. 90(5). 529–536. 103 indexed citations
7.
Murakami, T., Hirotake Nishimura, Shoji Hemmi, et al.. (2017). Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation. Journal of the Neurological Sciences. 381. 55–58. 7 indexed citations
8.
Ohsawa, Yutaka, Hideaki Ohtsubo, Shin‐ichiro Nishimatsu, et al.. (2017). Cleavage of β-dystroglycan occurs in sarcoglycan-deficient skeletal muscle without MMP-2 and MMP-9. Biochemical and Biophysical Research Communications. 492(2). 199–205. 7 indexed citations
9.
Imamura, Keiko, Naruhiko Sahara, Nicholas M. Kanaan, et al.. (2016). Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons. Scientific Reports. 6(1). 34904–34904. 69 indexed citations
10.
11.
Ohsawa, Yutaka, Kentaro Takayama, Shin‐ichiro Nishimatsu, et al.. (2015). The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy. PLoS ONE. 10(7). e0133713–e0133713. 25 indexed citations
12.
Kawai, Nobuhiko, Yutaka Ohsawa, Naozumi Ishimaru, et al.. (2013). Local Applications of Myostatin-siRNA with Atelocollagen Increase Skeletal Muscle Mass and Recovery of Muscle Function. PLoS ONE. 8(5). e64719–e64719. 20 indexed citations
13.
Murakami, T., Yutaka Ohsawa, Zhenghua Li, Ken–ichi Yamamura, & Yoshihide Sunada. (2010). The transthyretin gene is expressed in Schwann cells of peripheral nerves. Brain Research. 1348. 222–225. 31 indexed citations
14.
Murakami, T., et al.. (2010). Hereditary sensory ataxic neuropathy associated with proximal muscle weakness in the lower extremities. Journal of the Neurological Sciences. 291(1-2). 121–123. 1 indexed citations
15.
Ohsawa, Yutaka, Tadashi Okada, Shu A. HAYASHI, et al.. (2008). Caveolin-3 regulates myostatin signaling. Mini-review.. PubMed. 27. 19–24. 11 indexed citations
16.
Hagiwara, Hiroki, Yutaka Ohsawa, A. Shoji, et al.. (2006). Bone marrow transplantation improves outcome in a mouse model of congenital muscular dystrophy. FEBS Letters. 580(18). 4463–4468. 21 indexed citations
17.
Ohsawa, Yutaka, Hiroki Hagiwara, Masashi Nakatani, et al.. (2006). Muscular atrophy of caveolin-3–deficient mice is rescued by myostatin inhibition. Journal of Clinical Investigation. 116(11). 2924–2934. 95 indexed citations
18.
Ohsawa, Yutaka, Katsumi Kurokawa, Masahiro Sonoo, et al.. (2005). Reduced amplitude of the sural nerve sensory action potential in PARK2 patients. Neurology. 65(3). 459–462. 22 indexed citations
19.
Yamazaki, Kazuhisa, et al.. (2001). Interleukin‐10 gene promoter polymorphism in Japanese patients with adult and early‐onset periodontitis. Journal Of Clinical Periodontology. 28(9). 828–832. 78 indexed citations
20.
Yamazaki, Kazuhisa, Yutaka Ohsawa, & Hiromasa Yoshie. (2001). Elevated Proportion of Natural Killer T Cells in Periodontitis Lesions. American Journal Of Pathology. 158(4). 1391–1398. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiaki Ara Breakdown of academic impact, for papers by Yoshifumi Takahata Breakdown of academic impact, for papers by Akiko Mizokami Breakdown of academic impact, for papers by Tadahiko Iijima Breakdown of academic impact, for papers by Vu Thuong Nguyen Breakdown of academic impact, for papers by Denisse Sepúlveda Breakdown of academic impact, for papers by Haijiao Zhao Breakdown of academic impact, for papers by Lizheng Qin Breakdown of academic impact, for papers by Bradley K. Wacker
Rankless by CCL
2026